Bian, Huijie http://orcid.org/0000-0003-4690-4622
Zheng, Zhao-Hui
Wei, Ding
Wen, Aidong
Zhang, Zheng
Lian, Jian-Qi
Kang, Wen-Zhen
Hao, Chun-Qiu
Wang, Jing
Xie, Rong-Hua
Dong, Ke
Xia, Jie-Lai
Miao, Jin-Lin
Kang, Wen
Li, Guoquan
Zhang, Di
Zhang, Mingru
Sun, Xiu-Xuan
Ding, Likun
Zhang, Kui
Jia, Junfeng
Ding, Jin
Li, Zhiqin
Jia, Yanyan
Liu, Lin-Na
Zhang, Zhe
Gao, Zhao-Wei
Du, Hong
Yao, Na
Wang, Qing
Wang, Ke
Geng, Jie-Jie
Wang, Bin
Guo, Ting
Chen, Ruo
Zhu, Yu-Meng
Wang, Li-Juan
He, Qian
Yao, Rui-Rui
Shi, Ying
Yang, Xiang-Min
Zhou, Jian-Sheng
Ma, Yi-Nan
Wang, Ya-Tao
Liang, Xue
Huo, Fei
Wang, Zhe
Zhang, Yang
Yang, Xu
Zhang, Ye
Gao, Lu-Hua
Wang, Ling
Chen, Xiao-Chun
Tang, Hao
Liu, Shuang-Shuang
Wang, Qing-Yi
Chen, Zhi-Nan
Zhu, Ping
Funding for this research was provided by:
China National Science and Technology Major Project
Article History
Received: 8 February 2021
Revised: 8 March 2021
Accepted: 18 March 2021
First Online: 17 May 2021
Competing interests
: P.Z., Z.-N.C., H.B., and Z.Z. were the inventors of the patent Humanized anti-basigin antibodies and the use thereof (PCT/CN2017/082713), and all of the above authors were not the applicant or patentee of the patent. P.Z., Z.-N.C., H.B., D.W., and Z.Z. were the inventors of patent Humanized anti-basigin antibody for use of coronavirus disease 2019 (COVID-19) therapy (202010166717.9, China), and all of the above authors were not the applicant or patentee of the patent. The other authors declare no competing interests.